Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
Type:
Application
Filed:
November 16, 2017
Publication date:
March 15, 2018
Applicant:
Celularity, Inc.
Inventors:
Stewart Abbot, James Edinger, Aleksander Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav Padliya, Jennifer Paredes, Jia-Lun Wang
Abstract: The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.
Type:
Grant
Filed:
September 11, 2012
Date of Patent:
October 3, 2017
Assignee:
Celularity, Inc.
Inventors:
Mohit Bhatia, Chris Lugo, Qian Ye, James W. Edinger